Defence Therapeutics Inc (QB) (DTCFF)
USOTC
Fin d'année 30 Juin 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Return on Assets (%) | -70.434 | -76.037 | -232.075 | -318.034 | -658.005 |
Return on Equity (%) | -72.249 | -77.796 | -288.056 | -1148.217 | 1306.885 |
Return on Invested Capital (%) | -19.216 | -26.503 | -116.493 | -159.026 | 8354.902 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.098 | 0.154 | -0.012 | 0.035 | -0.079 |
Earnings Per Share | -0.036 | -0.081 | -0.2 | -0.154 | -0.29 |
Cash Per Share | 0.101 | 0.155 | 0.014 | 0.064 | 0.001 |
Working Capital Per Share | 0.098 | 0.154 | -0.012 | 0.073 | -0.084 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.036 | -0.081 | -0.2 | -0.157 | -0.29 |
EBITDA Per Share | -0.036 | -0.081 | -0.2 | -0.157 | -0.29 |
Free Cash Flow Per Share | -0.034 | -0.081 | -0.2 | -0.153 | -0.287 |
Fin d'année 30 Juin 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 18,47M | 35,22M | 36,63M | 43,78M | 45,54M |
Capitalisation boursière | 13,02M |
Ratio cours/bénéfice | -1,66 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 383,33 |
Ratio prix/valeur comptable | -6,11 |
Rendement de dividende | - |
Actions en circulation | 47,65M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 100 |
Variation sur 52 semaines | -72,38% |
Plus haut sur 52 semaines | 1,738 |
Plus bas sur 52 semaines | 0,2732 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales